COMMUNIQUÉS West-GlobeNewswire

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
20/10/2025
Cash, cash equivalents, short-term investments and other liquid assets expected to fund operations into 2029, beyond anticipated top-line results from the first Phase 3 clinical trial of BPL-003 NEW YORK and AMSTERDAM, [...]
Healios K.K. to Present at Chardan’s 9th Annual Genetic Medicines Conference
21/10/2025
NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- HEALIOS K.K. (“Healios”) is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the Chardan 9 th Annual Genetic Medicines Conference in New York [...]
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
21/10/2025
CALGARY, Alberta, Oct. 20, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing [...]
NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards
21/10/2025
EMERYVILLE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that it has regained compliance with the NYSE American’s continued listing [...]
Solana Company Executive Chairman’s Message: October 20th, 2025
20/10/2025
NEWTOWN, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Today, Solana Company (NASDAQ: HSDT) released the following letter from the Executive Chairman: We are excited to enter the next phase of our lifecycle with a strong [...]
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
20/10/2025
Taipei, Taiwan, Oct. 20, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025
RIYADH, Saudi Arabia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- In a historic leap for robotic medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first [...]
Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
20/10/2025
One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy in 16 patients with metastatic uveal melanoma in the ongoing Phase 1b trial continues to show strong clinical benefit with more mature [...]
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025
RIYADH, Saudi Arabia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- In a historic leap for robotic medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first [...]
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025
RIYADH, Saudi Arabia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- In a historic leap for robotic medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first [...]
IMPALA Appoints Ann Marie Dunne as New Chair, Succeeding Jonathan Taylor
20/10/2025
PISCATAWAY, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- IMPALA, a global consortium dedicated to advancing digital and analytics-driven quality in biopharmaceutical development, announced the appointment of Ann Marie Dunne [...]
ThrIVe Health Announces Patient Education Seminar Featuring Leading Thyroid Eye Disease Specialist Dr. Raymond Douglas
20/10/2025
World-Renowned Oculoplastic Surgeon Dr. Raymond Douglas and Board-Certified Endocrinologist Dr. Gladys E. Palomeno to Address Patients, Caregivers, and Healthcare Professionals Beverly Hills, CA, Oct. 20, 2025 (GLOBE [...]
Noom Launches AI Face Scan and AI Future Me to Bring Preventive Health Insights to Everyone
20/10/2025
Using AI and a smartphone camera, Noom makes personalized health screening and motivational tools accessible to all for free Noom’s free Face Scan feature PRINCETON, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Noom , the [...]
Anresco Laboratories and NJ Labs Unite to Form Nationwide Testing Network Built on Trusted, Proven Expertise
20/10/2025
LAS VEGAS, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Anresco Laboratories and NJ Labs —two of the nation’s most established analytical laboratories—have joined forces to establish Anresco NJ Labs , a nationwide network uniting [...]
Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference
20/10/2025
NORCROSS, Ga., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company management will [...]
Oncotelic to Present at the LD Micro Main Event XIX
20/10/2025
AGOURA HILLS, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC), a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat cancer [...]
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
20/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary [...]
STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek
20/10/2025
HORSHAM, Penn., Oct. 20, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025
20/10/2025
Adverse events (AEs) generally transient and readily manageable; only 2 cases of cytokine release syndrome (CRS) Prolonged tumor control with increasing doses of BA3182; confirmed partial response (cPR) at 0.6 mg in a [...]

Pages